Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

NCT06488066 is registered in ClinicalTrials.gov with Vance Thompson Vision as lead sponsor.

NCT NCT06488066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
Lead sponsor
Vance Thompson Vision
Phase
Observational
Overall status
Withdrawn
Start date
August 13, 2021
Completion date
January 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, pseudophakia